Cytokinetics, Incorporated CYTK

Full chart Compare
Set alert

Price alert · CYTK

All alert types
62.31 USD +0.28 (+0.45%)

At closeNov 3, 2026, 4:02 PM EST

62.31 0.00 0.00%

After hours · Nov 3, 4:02 PM ET

62.05 Day range 64.37
58.05 52-week range 88.31
YTD
-1.94%
1 year
+3.80%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 107.39 +72.3% upside
Target (low)
81.00
Target (mean)
107.39
Target (high)
140.00
Ratings (0m) 22 20 buy · 2 hold · 0 sell
  • Strong buy7
  • Buy13
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 22
  • 1 month ago 22
  • 2 months ago 22

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CYTK analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.41-1.65 – -1.10-1.54+8.8%42.34M+2086.8%18
Next quarter-1.39-1.76 – -1.02-1.50+7.4%62.59M+252.5%18
Current year-5.88-6.38 – -4.75-6.54+10.2%158.18M+79.7%18
Next year-4.40-5.90 – -3.14-5.88+25.1%430.63M+172.2%18

Upgrades and downgrades

The latest rating changes

CYTK analyst upgrades and downgrades
DateFirmActionFromTo
Oct 19, 2026HC Wainwright & Co.ReiteratedBuyBuy
Oct 16, 2026William BlairInitiated—Outperform
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Aug 31, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 13, 2026BarclaysMaintainedOverweightOverweight
Aug 13, 2026JP MorganMaintainedOverweightOverweight
Aug 10, 2026Truist SecuritiesMaintainedBuyBuy
Aug 7, 2026RBC CapitalMaintainedOutperformOutperform
Aug 7, 2026CitizensMaintainedMarket OutperformMarket Outperform
Aug 7, 2026NeedhamMaintainedBuyBuy
Jul 7, 2026RBC CapitalMaintainedOutperformOutperform
Jun 29, 2026UBSUpgradeNeutralBuy
Jun 24, 2026MizuhoMaintainedOutperformOutperform
Jun 17, 2026NeedhamReiteratedBuyBuy
May 19, 2026CitigroupInitiated—Buy
May 12, 2026JP MorganMaintainedOverweightOverweight
May 11, 2026HC Wainwright & Co.MaintainedBuyBuy
May 7, 2026Wells FargoMaintainedOverweightOverweight
May 6, 2026StifelMaintainedBuyBuy
May 6, 2026Morgan StanleyMaintainedOverweightOverweight
May 6, 2026RBC CapitalMaintainedOutperformOutperform
May 5, 2026NeedhamMaintainedBuyBuy
Apr 10, 2026Wells FargoInitiated—Overweight
Apr 6, 2026BarclaysMaintainedOverweightOverweight
Mar 18, 2026MizuhoMaintainedOutperformOutperform
Mar 17, 2026JP MorganMaintainedOverweightOverweight
Mar 6, 2026UBSMaintainedNeutralNeutral
Feb 26, 2026Leerink PartnersMaintainedOutperformOutperform
Feb 25, 2026CitizensMaintainedMarket OutperformMarket Outperform
Feb 25, 2026NeedhamMaintainedBuyBuy